INVESTIGACIÓN BÁSICA Y TRASLACIONAL EN ENFERMEDADES INFLAMATORIAS
INVEIN
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (5)
2023
-
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 754-762
-
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
RMD Open, Vol. 9, Núm. 1
-
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
RMD Open, Vol. 9, Núm. 1
2017
-
A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294
-
Overexpression of the cytokine BAFF and autoimmunity risk
New England Journal of Medicine, Vol. 376, Núm. 17, pp. 1615-1626